QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas

NCT02582827 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Enrollment not initiated

Conditions

Neoplastic Disease

Interventions

DRUG: ABI-011

Sponsor

NantBioScience, Inc.